Liability for defective medical implants or prosthetics in Georgia is handled primarily under product liability law, with claims possible against several parties in the manufacturing and distribution chain. Two features specific to medical devices, federal preemption and the learned intermediary doctrine, shape which claims can actually proceed, so they matter as much as the underlying product theory.
The product liability theories
Under O.C.G.A. § 51-1-11, a manufacturer can face strict product liability, where the plaintiff does not prove negligence but must show the device was defective when it left the manufacturer’s control (a design, manufacturing, or warning defect), the defect made it unreasonably dangerous, and the defect proximately caused the injury. A separate negligence theory reaches manufacturers or distributors that failed to use ordinary care in design, manufacture, testing, or marketing.
Healthcare providers and hospitals can also face liability where their own conduct fell below the standard of care, such as negligent selection of a defective or inappropriate device, improper implantation, failure to warn the patient of known risks, failure to monitor after surgery, or failure to act on a recall.
Federal preemption is often decisive
Whether a claim survives frequently depends on how the FDA approved the device. Under the U.S. Supreme Court’s decision in Riegel v. Medtronic (2008), devices that went through the FDA’s rigorous Premarket Approval (PMA) process, typically high-risk Class III devices, receive broad preemption: state-law claims that would impose requirements different from or in addition to the federal ones are barred. Claims that merely parallel federal requirements, such as a manufacturing defect or a violation of FDA rules, may still proceed. Devices cleared through the lighter 510(k) process generally do not receive that preemption, so most state-law claims can go forward.
The learned intermediary doctrine
Georgia recognizes the learned intermediary doctrine, under which a manufacturer can satisfy its duty to warn by giving adequate warnings to the prescribing physician rather than directly to the patient. In a failure-to-warn claim, that makes the adequacy of the warnings provided to physicians a key issue.
The statute of repose
Georgia’s ten-year product liability statute of repose (O.C.G.A. § 51-1-11(b)(2)), measured from the device’s first sale, can bar claims against manufacturers of older implants even when a defect causes a recent injury.
Proving these cases typically requires expert testimony from biomedical engineers, metallurgists, surgeons, and device specialists to identify the defect, connect it to the injury, and address whether medical standards were met.